Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Zoetis Inc.

< Previous 1 2 3 4 Next >
Zoetis Receives European Commission Marketing Authorization for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis Appoints Stephanie Tilenius to its Board of Directors
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis Announces Health Canada Approval of Lenivia® (izenivetmab injection) for Alleviation of Osteoarthritis (OA) Pain in Dogs
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis Receives Positive Opinion from CVMP for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis Declares Fourth Quarter 2025 Dividend
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis to Host Webcast and Conference Call on Third Quarter 2025 Financial Results
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis Receives Positive Opinion from CVMP for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis Announces Pricing of $1.85 Billion of Senior Notes
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis Announces Second Quarter 2025 Results, Raises Full Year 2025 Outlook
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis to Host Webcast and Conference Call on Second Quarter 2025 Financial Results
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis Releases 2024 Sustainability Progress Update
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Dr. Mark Stetter Elected to Zoetis Board of Directors
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis Declares Third Quarter 2025 Dividend
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis to Participate in Upcoming Investor Conferences
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis Announces First Quarter 2025 Results
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis to Host Webcast and Conference Call on First Quarter 2025 Financial Results
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis to Participate in Upcoming Investor Conferences
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis Receives Conditional License from USDA for Avian Influenza Vaccine, H5N2 Subtype, Killed Virus
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis Reports Fourth Quarter and Full Year 2024 Results
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis Declares Second Quarter 2025 Dividend
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis Announces U.S. Label Update for Librela® (bedinvetmab injection), a Treatment to Control Canine Osteoarthritis (OA) Pain
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2024 Financial Results
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis Declares First Quarter 2025 Dividend; Board Approves 16% Payment Increase
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis to Participate in the Piper Sandler 36th Annual Healthcare Conference
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis Appoints Jamie Brannan to Newly Created Chief Commercial Officer Role
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis to Participate in Jefferies London Healthcare Conference
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis Announces Third Quarter 2024 Results
From Zoetis Inc.
Via Business Wire
Tickers ZTS
Zoetis Declares Fourth Quarter 2024 Dividend
From Zoetis Inc.
Via Business Wire
Tickers ZTS
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.